Navigation Links
Dr. Kamiya and Dr. Citrolo to Discuss L-Citrulline’s Role as a Circulation Enhancer, and Promoter of Muscle Protein at SupplySide West

New York, NY (PRWEB) November 13, 2013

Dr. Toshikazu Kamiya, President and CEO at Kyowa Hakko USA, and Dr. Danielle Citrolo, Pharm.D and Registered Pharmacist at Kyowa Hakko USA will discuss the health benefits of Kyowa’s ultra-pure L-Citrulline at SupplySide West, Friday, November 15th, from 11 – 11:50 a.m. in the Sands Convention Center, VendorBrief Booth 14074 sponsored by Kyowa Hakko USA.

L-Citrulline is an amino acid that plays an important role in nitric oxide metabolism and regulation. L-Citrulline is converted to L-arginine in the body, leading to increased production of nitric oxide (NO) and effects such as vasodilation. It is expected to relieve muscle fatigue through promotion of energy production and ammonia elimination. Antioxidant action and heart protection action are also known.

Dr. Toshikazu Kamiya is the President and Chief Executive Officer of Kyowa Hakko USA. Prior to joining Kyowa Hakko USA he was the director of Kyowa Hakko Bio, Healthcare Products Development Center in Tsukuba, Japan. He received his Ph.D. in agricultural chemistry from the University of Tokyo and has worked on pharmaceutical and nutraceutical research for over 25 years at Kyowa Hakko Bio Co., Ltd. His continuous interest in research has expanded to collaboration with prestigious research facilities including Harvard University, Penn State Medical Center and Emory University.

Dr. Danielle Citrolo, Pharm.D. and Registered Pharmacist, is the Manager of Technical Services for Kyowa Hakko U.S.A. with responsibilities that include providing technical and scientific support to customers, maintaining Kyowa’s technical knowledge database, supporting regulatory affairs, and acting as liaison with regulatory authorities in the US, Canada and Latin America. Dr. Citrolo earned her BS in biochemistry and BA in chemistry from North Carolina State University, and her Doctor of Pharmacy degree from Albany College of Pharmacy in New York. She is licensed by the New York State Board of Pharmacy.

About Kyowa Hakko’s L-Citrulline
L-Citrulline is an amino acid that plays an important role in nitric oxide metabolism and regulation.* L-Citrulline is converted to L-Arginine in the body, leading to sustained increases in both L-Arginine and nitric oxide.* An ingredient with application in the areas of heart health and sports nutrition, L-Citrulline is preservative-free, allergen-free, and contains no artificial flavors or colors. Its low hygroscopicity, high stability, and mild taste makes it suitable for use in a variety of formulations. As proteins do not contain L-Citrulline, taking L-Citrulline is the sole way of direct supplementation of this unique amino acid to the body. Manufactured in the U.S. using a proprietary fermentation process, l-citrulline is an ultra-pure amino acid that carries the Kyowa Quality logo, ensuring you an ingredient backed by our commitment to the highest manufacturing standards. For more information on L-Citrulline, visit

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Kyowa Hakko USA
Kyowa Hakko USA is the North American sales office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Pantesin® Pantethine, Setria® Glutathione, as well as Sustamine™ L-Alanyl-L-Glutamine. For more information visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
2. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
3. Dr. Carol Francis Radio Talk Show Discusses Sexual Abuse as Related to "Coach" Jerry Sandusky; Interview With Abuse Survivor Teresa Joyce, Author of "There's A Fine Line"
4. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
5. Few Doctors Discuss Exercise With Cancer Patients: Study
6. Study demonstrates that earlier end of life care discussions are linked to less aggressive care in final days of life
7. Later End-of-Life Discussions May Mean More Aggressive Treatment
8. Internet Speaker, Founder, and President of RevenFlo Web Team, Jason Broadwater, Discusses the Most Essential Marketing Tool Available for Effective Internet Marketing
9. ‘A Subtle Addiction – Attacking the Y Generation’ the New Book by Peter and Lynn McIntosh Discusses Cell Phone Radiation - are Parents Nuking their Kids this Christmas?
10. Probiotic Action Responds to an Article Discussing the Health Benefits of Probiotics
11. Phoenix Synergy Discusses securing computer networks at the AZPMA conference in Las Vegas
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials of ... Narconon network, announced the release of a new cutting edge recovery program that has ... been working with drug- and alcohol-addicted individuals with the purpose to free addicts from ...
(Date:11/25/2015)... ... , ... Smiles by Stevens is pleased to announce the addition ... many patients are aware of the benefits of Botox® in the treatment of moderate ... with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... -- --> --> Juntendo ... optimal contrast weighting of MRI for patients with Multiple ... research agreement with SyntheticMR in order to use SyMRI in ... possible to generate multiple contrast images from a single scan ... thus making it possible to both fine tune images and ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
Breaking Medicine Technology: